The Venture Codex Logo

The Venture Codex

Overview

Bioresorbable scaffold technology for treating peripheral arterial disease.

Total Raised

$105 M

Rounds

3

Links

Verticals

Health Diagnostics
Manufacturing
Medical Device

Investment History

  1. Series B

    May 2024

    $87M

  2. Convertible Note

    Oct 2020

    $3M

Team

Kamal Ramzipoor

President and CEO

Christopher M. Owens

President and CEO

Josh Smale

Vice President, Global Clinical and Scientific Affairs

Afsoon Fallahi

Engineering